Clofarabine in Chronic Lymphocytic Leukemia

PHASE1CompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

February 28, 1999

Study Completion Date

March 31, 2004

Conditions
Hematologic NeoplasmsLymphoproliferative DisordersLeukemiaLeukemia, Lymphocytic, Chronic
Interventions
DRUG

Clofarabine

Trial Locations (1)

77030

University of Texas M. D. Anderson Cancer Center, Houston

All Listed Sponsors
lead

M.D. Anderson Cancer Center

OTHER